Matthew Boudreaux, MD
Colon & Rectal Surgery · Lafayette, LANPI 1245440577
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Johnson & Johnson at 27.5% of the total. Reporting peaked in 2022 at $130 and has fallen 64.3% since, to $46 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in LA, where the typical reported total is $4,339.
Across 15 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$61
- Sanara Medtech Inc.$55
- THD America, Inc.$29
- Merck$28
- BD$18
- Intuitive Surgical$16
- plus $17 from 2 others
What the payments were for
- Food & beverage$223100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 2 | $61 |
| Sanara Medtech Inc. | 6 | $55 |
| THD America, Inc. | 1 | $29 |
| Merck | 2 | $28 |
| BD | 1 | $18 |
| Intuitive Surgical | 1 | $16 |
| Innocoll Pharmaceuticals Limited | 1 | $14 |
| Akebia Therapeutics Inc | 1 | $3 |
How this compares
$223 in reported general payments places this provider in the 20th percentile of 39 colon & rectal surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 100 | $1,151 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 114 | $814 |
| Procto-Med HcHydrocortisone | 27 | $422 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $411 |
| CholestyramineCholestyramine (With Sugar) | 12 | $302 |
| Ciprofloxacin Hcl | 20 | $163 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $163 |
| Ondansetron Hcl | 52 | $161 |
| Dicyclomine Hcl | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Lafayette
- Michael HoraistLafayette$3K
- Bradley ChampagneLafayette$611
- Kenneth ChampagneLafayette$235
- Jennifer ParuchNew Orleans$63K
- Andrew WernerShreveport$22K
- Charles WhitlowNew Orleans$22K
- Brielle HebertShreveport$22K
- Jennifer SilinskyMetairie$21K
- Elyse Bevier-RawlsNew Orleans$18K
- Louis BarfieldBaton Rouge$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.